Skip to main content
Photo of Jonathan Parr
Jonathan Parr, MD, MPH

Jonathan Parr, MD, MPH, wrote an editorial that was published in the October 20, 2020 issue of JAMA Internal Medicine.

The editorial — titled “Time to Reassess Tocilizumab’s Role in COVID-19 Pneumonia” — reviews recently released randomized trials and concludes that the results “do not support the routine use of tocilizumab for COVID-19 in most settings.”